REVIEW
Ahead of Print

Testosterone, cardiomyopathies, and heart failure: a narrative review


1 Department of Cardiology, University of Medicine and Pharmacy, Craiova 200349, Romania
2 Department of Physiology, University of Medicine and Pharmacy, Craiova 200349, Romania

Correspondence Address:
Ionuţ Donoiu,
Department of Cardiology, University of Medicine and Pharmacy, Craiova 200349
Romania
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/aja.aja_80_20

PMID: 33433530

Testosterone exerts an important regulation of cardiovascular function through genomic and nongenomic pathways. It produces several changes in cardiomyocytes, the main actor of cardiomyopathies, which are characterized by pathological remodeling, eventually leading to heart failure. Testosterone is involved in contractility, in the energy metabolism of myocardial cells, apoptosis, and the remodeling process. In myocarditis, testosterone directly promotes the type of inflammation that leads to fibrosis, and influences viremia with virus localization. At the same time, testosterone exerts cardioprotective effects that have been observed in different studies. There is increasing evidence that low endogenous levels of testosterone have a negative impact in some cardiomyopathies and a protective impact in others. This review focuses on the interrelationships between testosterone and cardiomyopathies and heart failure.


[FULL TEXT] [PDF]
Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Diaconu R
    -  Donoiu I
    -  Mirea O
    -  Bălşeanu TA
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed525    
    PDF Downloaded30    

Recommend this journal